SK chemicals

본문바로가기

Company History

2010 ~ 2020's 2000's 1990's 1980's 1960 ~ 1970's

2000's

2009: Development of “ECOZEN®,” eco-friendly transparent heat-resistant copolyester; Establishment of SK Syntec; L/O of hemophilia treatment NBP601 for the first time for a new Korean bio drug; Establishment of ST Green Energy

L/O of hemophilia treatment NBP601 for the first time for a new Korean bio drug

▲ L/O of hemophilia treatment NBP601 for the first time for a new Korean bio drug

Acquired UB Care, a healthcare solution specialized company

▲ Acquired UB Care, a healthcare solution specialized company

2008: L/O of dementia treatment patch “SID710” for the first time for a Korean incrementally modified drug; Establishment of SK chemicals GmbH (German Frankfurt corporation); Acquired UB Care, a healthcare solution specialized company

2007: In2Gen merger; Launched “Mvix,” a new drug for treating erectile dysfunction; Establishment of Shanghai Branch of SK Pharma Beijing Co., Ltd.

2006: Dongshin Pharmaceutical was merged with SK chemicals; Development of biodiesel production technology

2005: Establishment of SK pharma Beijing Co., Ltd. (local invested subsidiary in China); Establishment of SK chemicals Suzhou Co., Ltd. (local invested subsidiary in China); Establishment of SK petrochemical (PTA/DMT business); Establishment of SK Utis; SK pharmaceutical was acquired by SK chemicals

Establishment of SK petrochemical

▲ Establishment of SK petrochemical

2002: Establishment of SK Eurochem (local invested subsidiary in Poland); Launched “Joins,” Korea's new natural No. 1 drug for arthritis

2001: Establishment of SK chemicals (Qingdao) Co., Ltd. (local invested subsidiary in China); Development of “SKYGREEN,” an eco-friendly high functional resin

2000: Split off of polyester fiber business sector, the establishment of joint venture HUVIS

2000's